[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DOP2004000970A - OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS - Google Patents

OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Info

Publication number
DOP2004000970A
DOP2004000970A DO2004000970A DO2004000970A DOP2004000970A DO P2004000970 A DOP2004000970 A DO P2004000970A DO 2004000970 A DO2004000970 A DO 2004000970A DO 2004000970 A DO2004000970 A DO 2004000970A DO P2004000970 A DOP2004000970 A DO P2004000970A
Authority
DO
Dominican Republic
Prior art keywords
compounds
treatment
neurodegenerative disorders
formula
oxazol
Prior art date
Application number
DO2004000970A
Other languages
Spanish (es)
Inventor
Yuhpyng Liang Chen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2004000970A priority Critical patent/DOP2004000970A/en
Publication of DOP2004000970A publication Critical patent/DOP2004000970A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de Formula en donde R3, R5, R6, R7 y Z, asi como otros valores enumerados con relacion a R3, R5, R6, R7 y Z son como se los define. Los compuestos de Formula I presentan actividad inhibidora de la producción de peptido A(3. Esta invencion se refiere ademas a composiciones farmaceuticas y metodos para tratar enfermedades, por ejemplo, enfermedades neurodegenerativas, i.e. enfermedad de Alzheimer, en un mamifero, que comprenden compuestos de Formula I.The present invention relates to compounds of Formula wherein R3, R5, R6, R7 and Z, as well as other values listed in relation to R3, R5, R6, R7 and Z are as defined. The compounds of Formula I exhibit inhibitory activity of the production of peptide A (3. This invention also relates to pharmaceutical compositions and methods for treating diseases, for example, neurodegenerative diseases, ie Alzheimer's disease, in a mammal, comprising compounds of Formula I.

DO2004000970A 2004-08-06 2004-08-06 OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS DOP2004000970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2004000970A DOP2004000970A (en) 2004-08-06 2004-08-06 OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2004000970A DOP2004000970A (en) 2004-08-06 2004-08-06 OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Publications (1)

Publication Number Publication Date
DOP2004000970A true DOP2004000970A (en) 2005-02-15

Family

ID=44261390

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2004000970A DOP2004000970A (en) 2004-08-06 2004-08-06 OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Country Status (1)

Country Link
DO (1) DOP2004000970A (en)

Similar Documents

Publication Publication Date Title
DOP2005000040A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CR7785A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
UY28450A1 (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
UY28484A1 (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2004000888A (en) BENZAMIDA 2-HYDROXI-3-DIAMINOALCANS (BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES
UY28144A1 (en) THERAPEUTIC AGENTS
BR0315158A (en) Pyrazole Compounds for the Treatment of Neurodegenative Disorders
ECSP066888A (en) SULFONAMID COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
UY28279A1 (en) FENACILO 2 -HIDROXI - 3 - DIAMINOALCANOS
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
MXPA05012196A (en) Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders.
BR0306855A (en) Method for the treatment of cognitive disorders
CR9815A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
UY28458A1 (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
BRPI0509559A (en) pyrazolamine compounds for the treatment of neurodegenerative disorders
DOP2004000970A (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2004000982A (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2004000966A (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
DOP2006000200A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL TRANSFERS
BRPI0509881A (en) therapeutic combination for treatment of alzheimer's disease
CU23591B7 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROVEGETATIVE DISORDERS
BRPI0402756A (en) method for treating cognitive disorders
PA8601101A1 (en) BENZAMIDA 2-HYDROXI-3-DIAMINOALCANS